124037 Sigma-AldrichAkt Inhibitor XIX, 3CAI - CAS 28755-03-5 - Calbiochem
The Akt Inhibitor XIX, 3CAI, also referenced under CAS 28755-03-5, controls the biological activity of Akt. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.
More>> The Akt Inhibitor XIX, 3CAI, also referenced under CAS 28755-03-5, controls the biological activity of Akt. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Less<<Synonymes: 3-Chloroacetyl-indole, 2-Chloro-1-(1H-indol-3-yl)ethanone
Produits recommandés
Aperçu
Replacement Information |
---|
Tableau de caractéristiques principal
CAS # | Empirical Formula |
---|---|
28755-03-5 | C₁₀H₈ClNO |
Prix & Disponibilité
Référence | Disponibilité | Conditionnement | Qté | Prix | Quantité | |
---|---|---|---|---|---|---|
124037-25MG |
|
Flacon en verre | 25 mg |
|
— |
References | |
---|---|
References | Kim, D.J., et al. 2011. Cancer Prev. Res. 4, 1842. |
Product Information | |
---|---|
CAS number | 28755-03-5 |
Form | Pink solid |
Hill Formula | C₁₀H₈ClNO |
Chemical formula | C₁₀H₈ClNO |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Purity | ≥98% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Identification Number | |
---|---|
Référence | GTIN |
124037-25MG | 4055977205831 |
Documentation
Akt Inhibitor XIX, 3CAI - CAS 28755-03-5 - Calbiochem FDS
Titre |
---|
Akt Inhibitor XIX, 3CAI - CAS 28755-03-5 - Calbiochem Certificats d'analyse
Titre | Numéro de lot |
---|---|
124037 |
Références bibliographiques
Aperçu de la référence bibliographique |
---|
Kim, D.J., et al. 2011. Cancer Prev. Res. 4, 1842. |